CHMP recommends 10 new medicines for approval in the EU
New recommendations to ensure these medicines reach those who need them most
Revised transparency rules for Clinical Trials Information System (CTIS) have become applicable
Board adopts Executive Director’s 2023 annual activity report and is updated on new fee regulation
EU collaboration to foster high-quality clinical research
How we contributed to public and animal health in the European Union
Find medicine
What's new
FAQs
Latest news
10 new medicines recommended for approval; another 11 medicines recommended for extension of their therapeutic indications
Winrevair received support through PRIority Medicines (PRIME) scheme due to its potential to bring a major therapeutic advantage over existing therapies
Eurneffy (epinephrine) is an alternative to injectable formulations
Benefits of Ocaliva no longer considered to outweigh its risks
Opinion follows review of additional data and advice from group of experts.
MSSG recommendations for all stakeholders and upcoming multistakeholder workshop
Information for you
Patients and carers
Healthcare professionals
Animal health professionals
Pharmaceutical Industry
Media
